ciprofloxacin has been researched along with nitazoxanide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
Gau, JS; Hu, MK; Kuo, LC; Lin, WP | 1 |
1 review(s) available for ciprofloxacin and nitazoxanide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for ciprofloxacin and nitazoxanide
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |
Nitazoxanide Analogues as Antimicrobial Agents Against Nosocomial Pathogens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Positive Endospore-Forming Rods; Microbial Sensitivity Tests; Nitro Compounds; Phthalimides; Structure-Activity Relationship; Sulfonamides; Thiazoles | 2016 |